StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report sent to investors on Thursday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Price Performance
ADXS opened at $0.03 on Thursday. The stock has a market capitalization of $1.15 million, a P/E ratio of 0.00 and a beta of 1.72. The company’s 50 day simple moving average is $0.03 and its 200-day simple moving average is $0.22. Ayala Pharmaceuticals has a one year low of $0.00 and a one year high of $1.49.
Ayala Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ayala Pharmaceuticals
- 10 Best Airline Stocks to Buy
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is Short Interest? How to Use It
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- The Most Important Warren Buffett Stock for Investors: His Own
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.